Sign inJoin waitlistJoin the waitlist

DP

David Piontkowsky

Internal Medicine

Credentials: ·

History

Internal Medicine

Research

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir…
The Lancet Infectious Diseases · 2014 · Last of 10 authors · 106 citations
Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and…
The Lancet Infectious Diseases · 2014 · 89 citations
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial
Infectious Diseases and Therapy · 2021 · 46 citations

RH
Richard Haubrich
6 papers
MD
Moupali Das
5 papers
Will Garner
5 papers · 5 as a resident
JG
Joel Gallant
4 papers
ED
Edwin Dejesus
3 papers
AV
Arvind Venkat
2 papers
CC
Calvin Cohen
2 papers
David Wohl
2 papers
JF
Jason Flamm
2 papers
Keith Henry
2 papers
MR
Martin Rhee
2 papers
MB
Matthew Bosse
2 papers